Titre : Rites funéraires

Rites funéraires : Questions médicales fréquentes

Termes MeSH sélectionnés :

Ganciclovir

Questions fréquentes et termes MeSH associés

Diagnostic 2

#1

Comment identifier un rite funéraire spécifique ?

L'identification se fait par l'analyse des symboles, des pratiques et des croyances culturelles.
Rites funéraires Culture
#2

Quels éléments caractérisent un rite funéraire ?

Les éléments incluent les rituels, les prières, les offrandes et les cérémonies d'enterrement.
Rites funéraires Cérémonies

Symptômes 2

#1

Quels sentiments peuvent émerger lors d'un rite funéraire ?

Les participants peuvent ressentir de la tristesse, de la colère, de la paix ou de la nostalgie.
Émotions Rites funéraires
#2

Comment le deuil se manifeste-t-il pendant un rite ?

Le deuil peut se manifester par des pleurs, des cris ou des comportements de commémoration.
Deuil Rites funéraires

Prévention 2

#1

Comment préparer un rite funéraire à l'avance ?

Il est conseillé de discuter des souhaits avec la famille et de rédiger des directives claires.
Planification Rites funéraires
#2

Quels documents sont nécessaires pour un rite funéraire ?

Les documents incluent le certificat de décès et les arrangements préalables si existants.
Documents légaux Rites funéraires

Traitements 2

#1

Quels soutiens psychologiques sont offerts lors des rites ?

Des conseillers ou des thérapeutes peuvent être présents pour aider les endeuillés.
Soutien psychologique Rites funéraires
#2

Comment les rites funéraires aident-ils au processus de deuil ?

Ils offrent un cadre pour exprimer la douleur et favoriser la mémoire du défunt.
Deuil Rites funéraires

Complications 2

#1

Quelles complications peuvent survenir lors d'un rite ?

Des conflits familiaux ou des désaccords sur les rituels peuvent survenir.
Conflits familiaux Rites funéraires
#2

Comment gérer les émotions intenses lors d'un rite ?

Il est important d'avoir un soutien émotionnel et de permettre l'expression des sentiments.
Soutien émotionnel Rites funéraires

Facteurs de risque 2

#1

Quels facteurs influencent les rites funéraires ?

Les facteurs incluent la culture, la religion, et les traditions familiales.
Culture Rites funéraires
#2

Comment le contexte social affecte-t-il les rites ?

Le contexte social peut déterminer la manière dont les rites sont perçus et pratiqués.
Contexte social Rites funéraires
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Rites funéraires : Questions médicales les plus fréquentes", "headline": "Rites funéraires : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Rites funéraires : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-06-27", "dateModified": "2025-03-24", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Rites funéraires" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Anthropologie culturelle", "url": "https://questionsmedicales.fr/mesh/D000884", "about": { "@type": "MedicalCondition", "name": "Anthropologie culturelle", "code": { "@type": "MedicalCode", "code": "D000884", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "I01.076.201" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Funérailles", "alternateName": "Burial", "url": "https://questionsmedicales.fr/mesh/D002048", "about": { "@type": "MedicalCondition", "name": "Funérailles", "code": { "@type": "MedicalCode", "code": "D002048", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "I01.076.201.450.550.150" } } }, { "@type": "MedicalWebPage", "name": "Crémation", "alternateName": "Cremation", "url": "https://questionsmedicales.fr/mesh/D055700", "about": { "@type": "MedicalCondition", "name": "Crémation", "code": { "@type": "MedicalCode", "code": "D055700", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "I01.076.201.450.550.175" } } }, { "@type": "MedicalWebPage", "name": "Embaumement", "alternateName": "Embalming", "url": "https://questionsmedicales.fr/mesh/D004615", "about": { "@type": "MedicalCondition", "name": "Embaumement", "code": { "@type": "MedicalCode", "code": "D004615", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "I01.076.201.450.550.250" } } } ], "about": { "@type": "MedicalCondition", "name": "Rites funéraires", "alternateName": "Funeral Rites", "code": { "@type": "MedicalCode", "code": "D005655", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Megumi Kondo-Arita", "url": "https://questionsmedicales.fr/author/Megumi%20Kondo-Arita", "affiliation": { "@type": "Organization", "name": "President's Office, Global Center of Osaka Medical and Pharmaceutical University, Takatsuki, Japan." } }, { "@type": "Person", "name": "Carl B Becker", "url": "https://questionsmedicales.fr/author/Carl%20B%20Becker", "affiliation": { "@type": "Organization", "name": "Policy Science Unit, School of Medicine, Kyoto University, Kyoto, Japan." } }, { "@type": "Person", "name": "Livia Sani", "url": "https://questionsmedicales.fr/author/Livia%20Sani", "affiliation": { "@type": "Organization", "name": "SULISOM UR 3071, Université de Strasbourg, France." } }, { "@type": "Person", "name": "Marie-Frédérique Bacqué", "url": "https://questionsmedicales.fr/author/Marie-Fr%C3%A9d%C3%A9rique%20Bacqu%C3%A9", "affiliation": { "@type": "Organization", "name": "SULISOM UR 3071, Université de Strasbourg, France." } }, { "@type": "Person", "name": "Yozo Taniyama", "url": "https://questionsmedicales.fr/author/Yozo%20Taniyama", "affiliation": { "@type": "Organization", "name": "Department of Religious Studies, Tohoku University, Sendai 980-8576, Japan." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Efficacy of ganciclovir versus foscarnet in ganciclovir-resistant cytomegalovirus retinitis: A case report.", "datePublished": "2022-10-30", "url": "https://questionsmedicales.fr/article/36314436", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1177/11206721221136316" } }, { "@type": "ScholarlyArticle", "name": "Ganciclovir-resistant cytomegalovirus retinitis in a 4-month-old infant.", "datePublished": "2022-09-22", "url": "https://questionsmedicales.fr/article/36152756", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.jaapos.2022.08.264" } }, { "@type": "ScholarlyArticle", "name": "Evidence supporting the use of therapeutic drug monitoring of ganciclovir in transplantation.", "datePublished": "2023-09-19", "url": "https://questionsmedicales.fr/article/37729654", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1097/QCO.0000000000000965" } }, { "@type": "ScholarlyArticle", "name": "A Case of Good Visual Outcome following Retinal Ganciclovir Toxicity.", "datePublished": "2022-09-09", "url": "https://questionsmedicales.fr/article/36084193", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1080/09273948.2022.2114917" } }, { "@type": "ScholarlyArticle", "name": "Population Pharmacokinetics of Ganciclovir in Allogeneic Hematopoietic Stem Cell Transplant Patients.", "datePublished": "2023-02-23", "url": "https://questionsmedicales.fr/article/36815858", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1128/aac.01550-22" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Sciences sociales", "item": "https://questionsmedicales.fr/mesh/D012942" }, { "@type": "ListItem", "position": 3, "name": "Anthropologie", "item": "https://questionsmedicales.fr/mesh/D000883" }, { "@type": "ListItem", "position": 4, "name": "Anthropologie culturelle", "item": "https://questionsmedicales.fr/mesh/D000884" }, { "@type": "ListItem", "position": 5, "name": "Rites funéraires", "item": "https://questionsmedicales.fr/mesh/D005655" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Rites funéraires - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Rites funéraires", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-19", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Rites funéraires", "description": "Comment identifier un rite funéraire spécifique ?\nQuels éléments caractérisent un rite funéraire ?", "url": "https://questionsmedicales.fr/mesh/D005655?mesh_terms=Ganciclovir#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Rites funéraires", "description": "Quels sentiments peuvent émerger lors d'un rite funéraire ?\nComment le deuil se manifeste-t-il pendant un rite ?", "url": "https://questionsmedicales.fr/mesh/D005655?mesh_terms=Ganciclovir#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Rites funéraires", "description": "Comment préparer un rite funéraire à l'avance ?\nQuels documents sont nécessaires pour un rite funéraire ?", "url": "https://questionsmedicales.fr/mesh/D005655?mesh_terms=Ganciclovir#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Rites funéraires", "description": "Quels soutiens psychologiques sont offerts lors des rites ?\nComment les rites funéraires aident-ils au processus de deuil ?", "url": "https://questionsmedicales.fr/mesh/D005655?mesh_terms=Ganciclovir#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Rites funéraires", "description": "Quelles complications peuvent survenir lors d'un rite ?\nComment gérer les émotions intenses lors d'un rite ?", "url": "https://questionsmedicales.fr/mesh/D005655?mesh_terms=Ganciclovir#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Rites funéraires", "description": "Quels facteurs influencent les rites funéraires ?\nComment le contexte social affecte-t-il les rites ?", "url": "https://questionsmedicales.fr/mesh/D005655?mesh_terms=Ganciclovir#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment identifier un rite funéraire spécifique ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "L'identification se fait par l'analyse des symboles, des pratiques et des croyances culturelles." } }, { "@type": "Question", "name": "Quels éléments caractérisent un rite funéraire ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Les éléments incluent les rituels, les prières, les offrandes et les cérémonies d'enterrement." } }, { "@type": "Question", "name": "Quels sentiments peuvent émerger lors d'un rite funéraire ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Les participants peuvent ressentir de la tristesse, de la colère, de la paix ou de la nostalgie." } }, { "@type": "Question", "name": "Comment le deuil se manifeste-t-il pendant un rite ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Le deuil peut se manifester par des pleurs, des cris ou des comportements de commémoration." } }, { "@type": "Question", "name": "Comment préparer un rite funéraire à l'avance ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Il est conseillé de discuter des souhaits avec la famille et de rédiger des directives claires." } }, { "@type": "Question", "name": "Quels documents sont nécessaires pour un rite funéraire ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les documents incluent le certificat de décès et les arrangements préalables si existants." } }, { "@type": "Question", "name": "Quels soutiens psychologiques sont offerts lors des rites ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Des conseillers ou des thérapeutes peuvent être présents pour aider les endeuillés." } }, { "@type": "Question", "name": "Comment les rites funéraires aident-ils au processus de deuil ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Ils offrent un cadre pour exprimer la douleur et favoriser la mémoire du défunt." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir lors d'un rite ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Des conflits familiaux ou des désaccords sur les rituels peuvent survenir." } }, { "@type": "Question", "name": "Comment gérer les émotions intenses lors d'un rite ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Il est important d'avoir un soutien émotionnel et de permettre l'expression des sentiments." } }, { "@type": "Question", "name": "Quels facteurs influencent les rites funéraires ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs incluent la culture, la religion, et les traditions familiales." } }, { "@type": "Question", "name": "Comment le contexte social affecte-t-il les rites ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Le contexte social peut déterminer la manière dont les rites sont perçus et pratiqués." } } ] } ] }
Dr Olivier Menir

Contenu validé par Dr Olivier Menir

Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale


Validation scientifique effectuée le 24/03/2025

Contenu vérifié selon les dernières recommandations médicales

Auteurs principaux

Megumi Kondo-Arita

4 publications dans cette catégorie

Affiliations :
  • President's Office, Global Center of Osaka Medical and Pharmaceutical University, Takatsuki, Japan.

Livia Sani

3 publications dans cette catégorie

Affiliations :
  • SULISOM UR 3071, Université de Strasbourg, France.

Marie-Frédérique Bacqué

3 publications dans cette catégorie

Affiliations :
  • SULISOM UR 3071, Université de Strasbourg, France.

Yozo Taniyama

3 publications dans cette catégorie

Affiliations :
  • Department of Religious Studies, Tohoku University, Sendai 980-8576, Japan.

Shinya Yamada

3 publications dans cette catégorie

Affiliations :
  • National Museum of Japanese History, Sakura 285-8502, Japan.

Kayoko Yamamoto

3 publications dans cette catégorie

Affiliations :
  • Department of Nursing, Tenri Health Care University, Tenri 632-0018, Japan.

Jacques Cherblanc

2 publications dans cette catégorie

Affiliations :
  • Human and Social Sciences, Université du Québec à Chicoutimi(UQAC), Saguenay, Canada.
Publications dans "Rites funéraires" :

Donna M Wilson

2 publications dans cette catégorie

Affiliations :
  • Registered Nurse, Professor, Faculty of Nursing, University of Alberta, Canada.
Publications dans "Rites funéraires" :

Suzanne Rainsford

2 publications dans cette catégorie

Affiliations :
  • Rural Clinical School, Australian National University Medical School, Australia.
Publications dans "Rites funéraires" :

Bruce Rumbold

2 publications dans cette catégorie

Affiliations :
  • Public Health Palliative Care Unit, School of Psychology and Public Health, La Trobe University, Melbourne, Australia.

Jennifer Lowe

2 publications dans cette catégorie

Affiliations :
  • Public Health Palliative Care Unit, School of Psychology and Public Health, La Trobe University, Melbourne, Australia.

Samar M Aoun

2 publications dans cette catégorie

Affiliations :
  • Public Health Palliative Care Unit, School of Psychology and Public Health, La Trobe University, Melbourne, Australia.
  • The Perron Institute for Neurological and Translational Science, Perth, Australia.

Iñigo Lorenzo Ruiz

2 publications dans cette catégorie

Affiliations :
  • Nursing Department, Faculty of Medicine and Nursing, University of the Basque Country UPV/EHU,Sarriena, Leioa, Spain.
  • BioCruces-Bizkaia Health Research Institute, Barakaldo, Spain.

Selom Komlan Noussoukpoe

2 publications dans cette catégorie

Affiliations :
  • Equipe de recherché de l'Association Togolaise pour le Bien-Etre Familial (ATBEF).

Willis Gwenzi

2 publications dans cette catégorie

Affiliations :
  • Biosystems and Environmental Engineering Research Group, Department of Soil Science and Agricultural Engineering, Faculty of Agriculture, University of Zimbabwe, P.O. Box MP167, Mount Pleasant, Harare, Zimbabwe. Electronic address: wgwenzi@agric.uz.ac.zw.

Noriko Sasaki

2 publications dans cette catégorie

Affiliations :
  • Department of Healthcare Economics and Quality Management, Graduate School of Medicine, Kyoto University, Kyoto 606-8501, Japan.

Veronica E Galimberti

1 publication dans cette catégorie

Affiliations :
  • Department of Immunobiology, Yale University School of Medicine, New Haven, CT.
  • Department of Neurology, Yale University School of Medicine, New Haven, CT.
Publications dans "Rites funéraires" :

Carla V Rothlin

1 publication dans cette catégorie

Affiliations :
  • Department of Immunobiology, Yale University School of Medicine, New Haven, CT.
  • Department of Pharmacology, Yale University School of Medicine, New Haven, CT.
Publications dans "Rites funéraires" :

Sourav Ghosh

1 publication dans cette catégorie

Affiliations :
  • Department of Neurology, Yale University School of Medicine, New Haven, CT.
  • Department of Pharmacology, Yale University School of Medicine, New Haven, CT.
Publications dans "Rites funéraires" :

Sources (134 au total)

Efficacy of ganciclovir versus foscarnet in ganciclovir-resistant cytomegalovirus retinitis: A case report.

To report a case of cytomegalovirus (CMV) retinitis improved by treatment with ganciclovir in a patient with ganciclovir-resistant CMV infection associated with Good syndrome.... Case report.... A 52-year-old gentleman with Good syndrome presented with visual disturbance in his right eye. He had a history of receiving intravitreal ganciclovir treatment with CMV retinitis a year ago. During tr... Even in the case of CMV retinitis, which has been genetically confirmed to be ganciclovir resistance in systemic blood, ganciclovir treatment can be considered if other anti-CMV agents are not effecti...

Evidence supporting the use of therapeutic drug monitoring of ganciclovir in transplantation.

This review describes current knowledge of ganciclovir (GCV) and valganciclovir (ValGCV) pharmacokinetic/pharmacodynamic characteristics, highlighting the likely contribution from host genetic factors... Pharmacokinetic studies of current dosing guidelines have shown high interindividual and intraindividual variability of GCV concentrations. This is sometimes associated with a slow decline in cytomega... Further studies examining novel biomarkers are needed to guide target concentrations in prophylaxis and treatment. The use of TDM in transplant recipients is likely to improve the clinical efficacy of...

Ganciclovir-induced mutations are present in a diverse spectrum of post-transplant malignancies.

Ganciclovir (GCV) is widely used in solid organ and haematopoietic stem cell transplant patients for prophylaxis and treatment of cytomegalovirus. It has long been considered a mutagen and carcinogen.... This retrospective cohort study analysed genomics data for 121,771 patients who had undergone targeted sequencing compiled by the Genomics Evidence Neoplasia Information Exchange (GENIE) or Foundation... Mutational profiles from 22 of 121,771 patient samples in the GENIE and FM cohorts showed evidence of GCV... In summary, GCV can cause a diverse range of cancers. Its mutagenicity may be potentiated by other therapies, such as mycophenolate, commonly co-prescribed with GCV for post-transplant patients. Furth...

Safety and efficacy of weight-based ganciclovir dosing strategies in overweight/obese patients.

The management of cytomegalovirus (CMV) is particularly challenging as both CMV and its usual first-line treatment, ganciclovir, are associated with neutropenia. Ganciclovir dosing is weight-based, mo... This retrospective study conducted safety and efficacy analyses of ganciclovir courses (≥72 h) used as CMV treatment. The primary safety outcome was the incidence of neutropenia (absolute neutrophil c... Among the 253 courses in the safety cohort, there was no difference in the incidence of neutropenia (17.4% vs. 13.5%, p = .50) in AdjBW compared to TBW dosing. In the 62 courses evaluating efficacy, t... Utilization of AdjBW ganciclovir dosing did not result in decreased neutropenia or treatment efficacy as compared to TBW dosing. Further studies with larger patient populations would be beneficial to ...

Prophylactic Pretransplant Ganciclovir to Reduce Cytomegalovirus Infection After Hematopoietic Stem Cell Transplantation.

Cytomegalovirus (CMV) reactivation remains a serious complication after allogeneic hematopoietic cell transplantation (HCT) occurring in approximately 60-70% of CMV-seropositive HCT recipients. CMV re... Ganciclovir was administered pretransplant at 5 mg/kg twice daily intravenously from the start of conditioning to Day T-2 to CMV-seropositive patients receiving their first allogeneic HCT. CMV DNA was... A total of 109 consecutive patients were treated, median age 57 (range 20-73) years. Of these, 36 (33%) patients had a CMV reactivation within the first 105 days posttransplant with a median time of r... The use of pretransplant ganciclovir was associated with low incidence of CMV reactivation and disease. These data suggest that pretransplant ganciclovir with preemptive therapy for viral reactivation...